FDA reform/PDUFA linkage endorsed by NDMA, Hutt tells annual meeting.
This article was originally published in The Tan Sheet
PDUFA/FDA REFORM LINKAGE ENDORSED BY NDMA, Covington & Burling attorney Peter Hutt told association members at the Nonprescription Drug Manufacturers Association's May 15-18 annual meeting in White Sulphur Springs, W.Va. Speaking during NDMA's "Report from Washington" panel presentation, Hutt noted the association's continuing efforts to lobby for inclusion of national uniformity provisions, as well as reauthorization of user fees for Rx-to-OTC switch and original NDAed OTC drugs, in FDA-related legislation under discussion on Capitol Hill.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC